606 related articles for article (PubMed ID: 8665870)
1. Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine.
Ferguson LR; Whiteside G; Holdaway KM; Baguley BC
Environ Mol Mutagen; 1996; 27(4):255-62. PubMed ID: 8665870
[TBL] [Abstract][Full Text] [Related]
2. Differences in inhibition of chromosome separation and G2 arrest by DNA topoisomerase II inhibitors merbarone and VM-26.
Chen M; Beck WT
Cancer Res; 1995 Apr; 55(7):1509-16. PubMed ID: 7882360
[TBL] [Abstract][Full Text] [Related]
3. Sister chromatid exchanges, chromosomal aberrations, and cytotoxicity produced by antitumor topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/9-OHE) Chinese hamster cells.
Pommier Y; Kerrigan D; Covey JM; Kao-Shan CS; Whang-Peng J
Cancer Res; 1988 Feb; 48(3):512-6. PubMed ID: 2825977
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle traverse in AHH-1 tk +/- human lymphoblastoid cells exposed to the chromosomal mutagen, m-amsa.
Morris SM; McGarrity LJ; Domon OE; Chen JJ; Casciano DA
Environ Mol Mutagen; 1996; 27(1):10-8. PubMed ID: 8625943
[TBL] [Abstract][Full Text] [Related]
5. Differential cell cycle-specificity for chromosomal damage induced by merbarone and etoposide in V79 cells.
Wang L; Roy SK; Eastmond DA
Mutat Res; 2007 Mar; 616(1-2):70-82. PubMed ID: 17174356
[TBL] [Abstract][Full Text] [Related]
6. Cell-cycle-specific chromosome damage following treatment of cultured Chinese hamster cells with 4'-[(9-acridinyl)-amino]methanesulphon-m-anisidide-HCl.
Deaven LL; Oka MS; Tobey RA
J Natl Cancer Inst; 1978 May; 60(5):1155-61. PubMed ID: 642032
[TBL] [Abstract][Full Text] [Related]
7. [Flow cytometric analysis of ICRF-193 influence on cell passage through mitosis].
Shatrova A; Aksenov ND; Zenin VV
Tsitologiia; 2002; 44(11):1068-78. PubMed ID: 12561727
[TBL] [Abstract][Full Text] [Related]
8. Topoisomerase II inhibitors affect entry into mitosis and chromosome condensation in BHK cells.
Anderson H; Roberge M
Cell Growth Differ; 1996 Jan; 7(1):83-90. PubMed ID: 8788036
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of genistein and amsacrine on leukemia cell proliferation.
Finlay GJ; Holdaway KM; Baguley BC
Oncol Res; 1994; 6(1):33-7. PubMed ID: 7919550
[TBL] [Abstract][Full Text] [Related]
10. Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth.
Hashimoto S; Chatterjee S; Ranjit GB; Bao C; Ford J; Ganapathi R; Berger SJ; Berger NA
Oncol Res; 1995; 7(7-8):407-16. PubMed ID: 8747604
[TBL] [Abstract][Full Text] [Related]
11. Characterization and mechanisms of chromosomal alterations induced by benzene in mice and humans.
Eastmond DA; Schuler M; Frantz C; Chen H; Parks R; Wang L; Hasegawa L
Res Rep Health Eff Inst; 2001 Jun; (103):1-68; discussion 69-80. PubMed ID: 11504146
[TBL] [Abstract][Full Text] [Related]
12. DNA-PKcs-dependent NHEJ pathway supports the progression of topoisomerase II poison-induced chromosome aberrant cells.
Elguero ME; de Campos-Nebel M; González-Cid M
Environ Mol Mutagen; 2012 Oct; 53(8):608-18. PubMed ID: 22987276
[TBL] [Abstract][Full Text] [Related]
13. The 1'-substituent on the anilino ring of the antitumor drug amsacrine is a critical element for topoisomerase II inhibition and cytotoxicity.
Rene B; Fosse P; Khelifa T; Jacquemin-Sablon A; Bailly C
Mol Pharmacol; 1996 Feb; 49(2):343-50. PubMed ID: 8632768
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic damage and the radiation-induced G1-phase checkpoint.
Gupta N; Vij R; Haas-Kogan DA; Israel MA; Deen DF; Morgan WF
Radiat Res; 1996 Mar; 145(3):289-98. PubMed ID: 8927696
[TBL] [Abstract][Full Text] [Related]
15. [Effect of etoposide and amsacrine on mitotic progression of GM-130 and Hep-2 cell lines. The flow cytometry assay].
Shatrova AN; Aksenov ND; Poletaev AI; Zenin VV
Tsitologiia; 2003; 45(1):59-68. PubMed ID: 12683237
[TBL] [Abstract][Full Text] [Related]
16. Megabase pair deletions in mutant mammalian cells following exposure to amsacrine, an inhibitor of DNA topoisomerase II.
Shibuya ML; Ueno AM; Vannais DB; Craven PA; Waldren CA
Cancer Res; 1994 Feb; 54(4):1092-7. PubMed ID: 8313366
[TBL] [Abstract][Full Text] [Related]
17. Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line.
Sullivan DM; Eskildsen LA; Groom KR; Webb CD; Latham MD; Martin AW; Wellhausen SR; Kroeger PE; Rowe TC
Mol Pharmacol; 1993 Feb; 43(2):207-16. PubMed ID: 8094226
[TBL] [Abstract][Full Text] [Related]
18. The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs.
Potter AJ; Rabinovitch PS
Mutat Res; 2005 May; 572(1-2):27-44. PubMed ID: 15790488
[TBL] [Abstract][Full Text] [Related]
19. Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol.
Adlakha RC; Ashorn CL; Chan D; Zwelling LA
Cancer Res; 1989 Apr; 49(8):2052-8. PubMed ID: 2539251
[TBL] [Abstract][Full Text] [Related]
20. Novobiocin, nalidixic acid, etoposide, and 4'-(9-acridinylamino)methanesulfon-m-anisidide effects on G2 and mitotic Chinese hamster ovary cell progression.
Rowley R; Kort L
Cancer Res; 1989 Sep; 49(17):4752-7. PubMed ID: 2474373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
